Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics today announced that it received notification from the Nasdaq on Wednesday that it has regained compliance with a listing requirement calling for a minimum closing bid price on the company's stock of at least $1 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.